Citation Tools
Ovarian cancer
297 Leap-005: evaluating the safety and efficacy of lenvatinib and pembrolizumab in patients previously treated for ovarian cancer, a multi-cohort phase 2 study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 297 Leap-005: evaluating the safety and efficacy of lenvatinib and pembrolizumab in patients previously treated for ovarian cancer, a multi-cohort phase 2 study